We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy.
CAT No: R1116
CAS No: 168650-46-2
Synonyms/Alias: 168650-46-2;[Asp371]-Tyrosinase (369-377), human;2-[[5-amino-2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoic acid;2,2,2-trifluoroacetic acid;(Asp371)-Tyrosinase (369-377) (human) acetate salt;168650-46-2(free basis);H-Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val-OH; H-YMDGTMSQV-OH;YMDGTMSQV;Asp371;Tyrosinase 369-377;FA73646;DA-69124;FA109106;FA110240;[Asp371] Tyrosinase(369-377), human;(Asp371)-Tyrosinase (369-377) (human) trifluoroacetate salt;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C44H67F3N10O18S2 |
M.W/Mr. | 1145.2 |
Sequence | One Letter Code:YMDGXMSQV Three Letter Code:H-DL-Tyr-DL-Met-DL-Asp-Gly-DL-xiThr-DL-Met-DL-Ser-DL-Gln-DL-Val-OH.TFA |
Areas of Interest | Antigen-presenting Cells; Cancer Research |
Source# | Homo sapiens (human) |
Restricting HLA | HLA-A2 |
InChI | InChI=1S/C42H66N10O16S2.C2HF3O2/c1-20(2)33(42(67)68)52-39(64)25(10-11-30(44)56)47-40(65)29(19-53)50-38(63)27(13-15-70-5)48-41(66)34(21(3)54)51-31(57)18-45-36(61)28(17-32(58)59)49-37(62)26(12-14-69-4)46-35(60)24(43)16-22-6-8-23(55)9-7-22;3-2(4,5)1(6)7/h6-9,20-21,24-29,33-34,53-55H,10-19,43H2,1-5H3,(H2,44,56)(H,45,61)(H,46,60)(H,47,65)(H,48,66)(H,49,62)(H,50,63)(H,51,57)(H,52,64)(H,58,59)(H,67,68);(H,6,7) |
InChI Key | TWALUFAMCVRLBU-UHFFFAOYSA-N |
References | Zhigang Wang; Cell Transplant 2015 |
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com